The global Genomics Market, valued at US$44.52 billion in 2024, stood at US$47.07 billion in 2025 and is projected to advance ...
Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology ...